Finance

Lists
Why is JSPR down 12,15%?
Dive Deeper
JSPR:NASDAQ
Jasper Therapeutics Inc
US$10,34
-12,15%
(-1,43) 1D
17 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Open
US$11,96
High
US$12,00
Low
US$9,25
Mkt. cap
11,47 ລ້ານ
Avg. vol.
21,07 ພັນ
Volume
49,07 ພັນ
52-wk high
US$72,60
52-wk low
US$9,25
EPS
US$-47,40
Beta
3,30
Shares outstanding
1,11 ລ້ານ
No. of employees
22
Open
US$11,96
High
US$12,00
Low
US$9,25
Mkt. cap
11,47 ລ້ານ
Avg. vol.
21,07 ພັນ
Volume
49,07 ພັນ
52-wk high
US$72,60
52-wk low
US$9,25
EPS
US$-47,40
Beta
3,30
Shares outstanding
1,11 ລ້ານ
No. of employees
22
News stories
From web sources and news partners
About Jasper Therapeutics Inc
CEO-
Employees22
Founded-
HeadquartersRedwood City, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to JSPR in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current US$10,34
US$600,00 (+5.702,71%)
Average
US$322,00 (+3.014,12%)
Lowest
US$44,00 (+325,53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Biren Amin
Piper Sandler
Buy
Maintained
US$44,00
+325,5%
11/17/2026
Matt Phipps
William Blair
Buy
Initiated
-
-
10/14/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
US$600,00
+5.702,7%
09/21/2026
Leonid Timashev
RBC Capital
Hold
Maintained
US$3,00
-71%
05/14/2026
Yaron Werber
TD Cowen
Hold
Downgraded
-
-
05/15/2026
David Dai
UBS
Hold
Maintained
US$1,50
-85,5%
04/02/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
US$7,00
-32,3%
04/01/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$17,00
+64,4%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google